Brief HIV Prevention Counseling for STI Patients in South Africa
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01242501|
Recruitment Status : Completed
First Posted : November 17, 2010
Last Update Posted : November 17, 2010
|Condition or disease||Intervention/treatment||Phase|
|Sexually Transmitted Infections||Behavioral: 60 Minute HIV/STI risk reduction counseling Behavioral: 20-Min education session||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||617 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Outcomes Assessor)|
|Official Title:||Randomized Trial of a Brief HIV Risk Reduction Counseling Intervention for Sexually Transmitted Infections Clinic Patients in Cape Town, South Africa|
|Study Start Date :||August 2005|
|Actual Primary Completion Date :||August 2010|
|Actual Study Completion Date :||August 2010|
Experimental: 60 Min. Risk Reduction Counseling
Single 60 min theory-based counseling session delivered in STI clinic setting in Cape Town South Africa.
Behavioral: 60 Minute HIV/STI risk reduction counseling
Single session risk reduction counseling delivered in STI clinic settings in South Africa.
Active Comparator: 20-min single session education
Single brief HIV/STI education only session for men and women receiving sexually transmitted infection clinic services in South Africa.
Behavioral: 20-Min education session
Patients receive a single 20 min education session for STI/HIV information.
- Chart abstracted sexually transmitted infections [ Time Frame: 12 month aggregate ]STI clinic chart abstracted diagnoses over 12 month observation period.
- Sexual behavior change [ Time Frame: 3-month intervals ]Computer assisted interview behavioral assessments of sexual risk and risk reduction.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01242501
|United States, Connecticut|
|University of Connecticut|
|Storrs, Connecticut, United States, 06269|
|Principal Investigator:||Seth Kalichman, Ph.D.||University of Connecticut|